Diagnostic Challenges and Clinical Implications of Seromucinous Ovarian Neoplasm in Anatomical Dissection: A Case Report Seromucinous Ovarian Neoplasm:
Main Article Content
Abstract
Ovarian cysts are a common finding, yet their discovery in cadavers during anatomical dissection is relatively rare. Seromucinous ovarian neoplasms represent a distinct subtype of ovarian epithelial tumors, often exhibiting benign behavior. While these tumors typically present with clinical symptoms, their incidental discovery in asymptomatic individuals underscores the diagnostic challenges. The cadaver in this study belonged to a 67-year-old woman with no known medical history of ovarian pathology or related symptoms. Medical records revealed no previous surgeries or interventions related to the reproductive system. The decedent did not report pelvic pain, abnormal uterine bleeding, or palpable abdominal masses during her lifetime. Gross examination revealed an incidental ovarian mass measuring 12x10x5.5 cm, characterized by an enlarged, congested, and cystic external surface. Further examination of the cut surface revealed multiloculated and mucoid material filling the cyst cavity, estimated to be approximately 250 cc in volume. Histopathological examination using hematoxylin and eosin (H&E) stained slides confirmed the diagnosis of a seromucinous ovarian neoplasm. Microscopic analysis depicted a lamellated cyst wall with a single layer of bland mucinous and serous epi-thelium, accompanied by mucoid secretions. The incidental discovery of a seromucinous ovarian neoplasm in this cadaver underscores the diagnostic challenges associated with ovarian pathology, even in the absence of clinical symptoms. This case highlights the importance of thorough anatomical dissections and understanding of the histopathological features of seromucinous tumors essential for accurate diagnosis and appropriate management strategies.
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Talia K, Parra-Herran C, McCluggage W. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach. Histopathology. 2022;80:255-78.
Storms A, Sukumvanich P, Monaco S, Beriwal S, Krivak T, Olawaiye A, et al. Mucinous tumors of the ovary: diagnostic challenges at frozen section and clinical implications. Gynecol Oncol. 2012;125:75-9.
Choi J, Sohn G, Chay D, Cho H, Kim J. Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas. Obstet Gynecol Sci. 2018; 61:344-51.
Kurman R, Shih I. Seromucinous tumors of the ovary. What’s in a name? Int J Gynecol Pathol. 2016;35:78-81.
Nagamine M, Mikami Y. Ovarian seromucinous tumors: pathogenesis, morphologic spectrum, and clinical issues. Diagnostics (Basel). 2020;10:1-9.
Karpathiou G, Chauleur C, Corsini T, Venet M, Habougit C, Honeyman F, et al. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors. Ann Diagn Pathol. 2017;27:28-33.
Abu Sulb A, Abu El Haija M, Muthukumar A. Incidental finding of a huge ovarian serous cystadenoma in an adolescent female with menorrhagia. SAGE Open Med Case Rep. 2016;4:2050313X16645755. PubMed PMID: 27489715
Limaiem F, Lekkala MR, Mlika M. Ovarian cystadenoma. StatPearls [Internet]. 2019. Available from: https://pubmed.ncbi.nlm.nih.gov/30725635/
Seidman J, Krishnan J. Ovarian epithelial inclusions with mucinous differentiation: a clinicopathologic study of 42 cases. Int J Gynecol Pathol. 2017;36:372-6.
Yeika E, Efie D, Tolefac P, Fomengia J. Giant ovarian cyst masquerading as a massive ascites: a case report. BMC Res Notes. 2017;10:1-4.
Jo V, Fletcher C. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014;46:95-104.
Rutgers J, Scully R. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer. 1988;61:340-8.
Rutgers J, Scully R. Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type: A clinicopathologic analysis. Cancer. 1988;61: 546-54.
Hauptmann S, Friedrich K, Redline R, Avril S. Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria. Virchows Arch. 2017;470:125-42.
Shappell H, Riopel M, Sehdev A, Ronnett B, Kurman R. Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol. 2002;26:1529-41.
Rodriguez I, Irving J, Prat J. Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol. 2004;28: 1311-8.
Dubé V, Roy M, Plante M, Renaud M, Têtu B. Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas. Int J Gynecol Pathol. 2005;24:138-46.
Hada T, Miyamoto M, Ishibashi H, Kawauchi H, Soyama H, Matsuura H, et al. Ovarian seromucinous borderline tumors are histologically different from mucinous borderline tumors. In Vivo. 2020;34:1341-6.